跳至主要内容
临床试验/EUCTR2016-000338-23-GB
EUCTR2016-000338-23-GB进行中(未招募)1 期

Does a low exhaled Nitric Oxide level exclude a clinical benefit from inhaled corticosteroids in suspected asthma; a double-blind, randomised, placebo controlled trial. - Low exhaled NO and inhaled corticosteroids in suspected asthma

niversity of Nottingham0 个研究点目标入组 165 人开始时间: 2016年2月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Aged 18 years or over.
  • Asthma suspected by GP / Practice Nurse
  • Low Exhaled Nitric Oxide reading <27ppb
  • Must be able to give informed consent freely
  • FEV1 >70% predicted
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 140
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • Patients requiring oral steroid treatment on visit to GP/Practice nurse
  • Use of oral prednisolone or antibiotics within last 4 weeks
  • Already using an inhaled corticosteroid
  • Any other clinically significant co-morbidity inc., bronchiectasis, COPD
  • Expectant or breast-feeding mothers

研究者

发起方
niversity of Nottingham

相似试验